CommercialCoverageMedium impact
08.02.17, Pozelimab-bbfg (Veopoz®)
Independence Blue Cross·Oncology, Hematology, Rheumatology +1 more·Pharmacy
Effective date
May 28, 2025
We identified it
Jun 19, 2026
Summary
A commercial insurance policy for Pozelimab-bbfg (Veopoz®), a pharmacy benefit drug, has been updated and will be reissued effective May 28, 2025. This appears to be a routine policy reissuance without specific details about coverage changes provided in the summary.
Action Required
By May 28, 2025: Billing team should review the full policy details at the provided URL to understand any changes to coverage, prior authorization requirements, or billing procedures for Pozelimab-bbfg (Veopoz®). Update billing system and staff training as needed based on the complete policy content.